
Insurance brokerage firm Brown & Brown (NYSE:BRO) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 30.4% year on year to $1.68 billion. Its non-GAAP profit of $1.07 per share was in line with analysts’ consensus estimates.
Is now the time to buy BRO? Find out in our full research report (it’s free for active Edge members).
Brown & Brown’s second quarter results for 2026 fell short of market revenue expectations, but sales still rose 30.4% year on year to $1.68 billion. Management attributed performance to strong contingent commissions, effective integration of acquisitions, and ongoing enhancements to its sales and underwriting processes. CEO J. Powell Brown emphasized, “Our enhanced go-to-market sales model is building momentum with newly aligned teams collaborating, developing opportunities, and generating incremental new business wins.” The company also noted progress in controlling expenses, even as operating margin declined year-over-year, and highlighted solid cash flow generation and share repurchases as additional contributors to the quarter’s outcomes.
Looking forward, Brown & Brown’s guidance is shaped by expectations for continued organic growth, efficiency gains from AI initiatives, and disciplined capital deployment. Management is focused on leveraging new technology partnerships to enhance productivity and accelerate workflow improvements. CFO R. Watts stated, “We anticipate incremental organic growth and margin expansion will occur over the coming quarters and years as AI, data, and analytics become more embedded in our workflows.” The company is also preparing for ongoing competitive pressures in commercial insurance pricing and is targeting further integration synergies from recent acquisitions, while maintaining flexibility to redirect capital between share repurchases, technology investments, and selective M&A.
Management cited robust contingent commission growth, successful integration of Accession, and early returns from enhanced technology and AI partnerships as key drivers of Q2 performance.
Management expects future performance to be driven by further integration benefits, AI-enabled efficiency gains, and disciplined capital allocation amid a competitive insurance market.
In the coming quarters, the StockStory team will be monitoring (1) the pace and impact of AI adoption across sales and underwriting workflows, (2) realization of cost synergies and integration benefits from the Accession acquisition, and (3) trends in contingent commissions and organic growth as insurance market competition intensifies. The effectiveness of capital allocation between share repurchases, technology investment, and future M&A will also be important for long-term performance.
Brown & Brown currently trades at $73.17, up from $67.76 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.